Methodological Utility of Chemerin as a Novel Biomarker of Immunity and Metabolism.

Measuring agreement in method comparison studies. Stat Methods Med Res (1999) 31.11

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77

Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med (2003) 3.91

Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology (2007) 3.01

Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem (2007) 2.85

Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med (2008) 2.54

Chemerin--a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun (2007) 2.00

Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol (2011) 1.95

EPIC-Germany--A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab (1999) 1.87

Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun (2009) 1.74

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett (2008) 1.51

Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol (1997) 1.50

Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol (2012) 1.45

Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes (2008) 1.42

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med (2011) 1.42

Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J Biol Chem (2010) 1.28

Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes (2009) 1.25

Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab (2010) 1.20

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol (2010) 1.13

Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis (2010) 1.11

Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract (2010) 0.95

Metabolic functions of FABPs--mechanisms and therapeutic implications. Nat Rev Endocrinol (2015) 0.94

Increased serum chemerin concentration in patients with chronic pancreatitis. Dig Liver Dis (2011) 0.87

Chemerin: A comprehensive review elucidating the need for cardiovascular research. Pharmacol Res (2015) 0.83

Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis. PLoS One (2014) 0.81

Reproducibility of Retinol Binding Protein 4 and Omentin-1 Measurements over a Four Months Period: A Reliability Study in a Cohort of 207 Apparently Healthy Participants. PLoS One (2015) 0.79

Novel adipokines: methodological utility in human obesity research. Int J Obes (Lond) (2017) 0.77

Serum chemerin is associated with inflammatory and metabolic parameters-results of a population-based study. Obesity (Silver Spring) (2017) 0.77